BioImpact Capital LLC, 10% Owner at iTeos Therapeutics, Inc. (ITOS), sold 279,546 shares at $34.62 ($9.6M) on 2021-11-30, disclosed to the SEC on 2021-12-02.
Open-market sale of $9.6M ITOS by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $34.62 | 9,809 | $340K | 3.5% |
| 2 | $34.62 | 9,809 | $340K | 3.5% |
| 3 | $35.19 | 46,992 | $1.7M | 17.2% |
| 4 | $35.19 | 46,992 | $1.7M | 17.2% |
| 5 | $33.82 | 10,111 | $342K | 3.5% |
| 6 | $33.82 | 10,111 |
| $342K |
| 3.5% |
| 7 | $34.61 | 9,131 | $316K | 3.3% |
| 8 | $34.61 | 9,131 | $316K | 3.3% |
| 9 | $35.34 | 1,500 | $53K | 0.6% |
| 10 | $35.34 | 1,500 | $53K | 0.6% |
| 11 | $33.74 | 49,796 | $1.7M | 17.4% |
| 12 | $33.74 | 49,796 | $1.7M | 17.4% |
| 13 | $34.83 | 12,434 | $433K | 4.5% |
| 14 | $34.83 | 12,434 | $433K | 4.5% |
| Total | $34.47 avg | 279,546 | $9.6M | 100% |
| Filing → |
| CGEM | SELL | 2021-09-16 | $602K | — | Filing → |
| CGEM | SELL | 2021-09-13 | $1.4M | — | Filing → |
| ITOS | SELL | 2021-09-13 | $5.5M | — | Filing → |